New York State Common Retirement Fund Sells 1 Shares of Pharmerica Corporation (PMC)

New York State Common Retirement Fund decreased its position in shares of Pharmerica Corporation (NYSE:PMC) by 0.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,854 shares of the company’s stock after selling 1 shares during the quarter. New York State Common Retirement Fund owned about 0.16% of Pharmerica Corporation worth $1,282,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. increased its holdings in shares of Pharmerica Corporation by 124.5% during the second quarter. Russell Investments Group Ltd. now owns 4,886 shares of the company’s stock valued at $128,000 after acquiring an additional 2,710 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Pharmerica Corporation during the first quarter valued at approximately $121,000. State of Alaska Department of Revenue increased its holdings in shares of Pharmerica Corporation by 79.8% during the second quarter. State of Alaska Department of Revenue now owns 6,112 shares of the company’s stock valued at $160,000 after acquiring an additional 2,712 shares in the last quarter. Aperio Group LLC bought a new stake in shares of Pharmerica Corporation during the second quarter valued at approximately $209,000. Finally, Tudor Investment Corp ET AL increased its holdings in shares of Pharmerica Corporation by 4.7% during the first quarter. Tudor Investment Corp ET AL now owns 8,602 shares of the company’s stock valued at $201,000 after acquiring an additional 389 shares in the last quarter. Hedge funds and other institutional investors own 90.86% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/11/01/new-york-state-common-retirement-fund-sells-1-shares-of-pharmerica-corporation-pmc.html.

Shares of Pharmerica Corporation (PMC) opened at 29.30 on Wednesday. Pharmerica Corporation has a 12-month low of $19.20 and a 12-month high of $29.50. The company has a market cap of $911.85 million, a P/E ratio of 39.70 and a beta of 0.84. The stock’s 50 day moving average price is $29.16 and its 200 day moving average price is $26.97.

Pharmerica Corporation (NYSE:PMC) last released its earnings results on Wednesday, August 2nd. The company reported $0.47 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.47. The company had revenue of $592.00 million during the quarter, compared to analysts’ expectations of $592.96 million. Pharmerica Corporation had a return on equity of 10.94% and a net margin of 1.05%. The firm’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.47 EPS. On average, analysts forecast that Pharmerica Corporation will post $1.94 EPS for the current year.

Several equities research analysts have recently commented on PMC shares. Zacks Investment Research downgraded Pharmerica Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. BidaskClub downgraded Pharmerica Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 31st. KeyCorp downgraded Pharmerica Corporation to an “overweight” rating in a report on Wednesday, August 2nd. Barrington Research downgraded Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a report on Thursday, August 3rd. Finally, UBS AG restated a “neutral” rating and set a $29.25 price objective (up previously from $26.00) on shares of Pharmerica Corporation in a report on Thursday, August 3rd. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $30.50.

About Pharmerica Corporation

Institutional Ownership by Quarter for Pharmerica Corporation (NYSE:PMC)

What are top analysts saying about Pharmerica Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Pharmerica Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit